Tuberculosis, HIV, and type 2 diabetes mellitus: A neglected priority

The Lancet Respiratory Medicine

Volumn 1, Issue 5, 2013, Pages 356-358

  Oni, Tolu ^a   Stoever, Kari ^b   Wilkinson, Robert J ^a,c,d  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b AERAS   (United States)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

^d NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EFAVIRENZ; ISONIAZID; NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR; PROTEINASE INHIBITOR; RIFAMPICIN;

CD4 LYMPHOCYTE COUNT; COMMUNICABLE DISEASE; COST OF ILLNESS; DEVELOPING COUNTRY; DISEASE ASSOCIATION; DRUG EFFICACY; DRUG METABOLISM; DYSGLYCEMIA; DYSLIPIDEMIA; GLYCEMIC CONTROL; GROSS NATIONAL PRODUCT; HEALTH CARE FINANCING; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INSULIN RESISTANCE; LIPODYSTROPHY; LUNG TUBERCULOSIS; MIXED INFECTION; MULTIDRUG RESISTANT TUBERCULOSIS; NEGLECTED DISEASE; NON COMMUNICABLE DISEASE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; NOTE; OBESITY; PRIORITY JOURNAL; PRODUCTIVITY; PUBLIC HEALTH PROBLEM; PUBLIC HEALTH SERVICE; RISK ASSESSMENT; RISK FACTOR; SCREENING TEST; SOUTH AFRICA; TUBERCULOSIS CONTROL; URBANIZATION; COMPLICATION; DIABETES MELLITUS, TYPE 2; ECONOMICS; HEALTH; HIV INFECTIONS; TUBERCULOSIS;

DIABETES MELLITUS, TYPE 2; GLOBAL HEALTH; HIV INFECTIONS; HUMANS; TUBERCULOSIS;

EID: 84881345828     PISSN: 22132600     EISSN: None     Source Type: Journal    
DOI: 10.1016/S2213-2600(13)70116-4     Document Type: Letter

References (16)

1. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004; 27: 1047-53.
2. WHO. Global status report on non-communicable diseases. Geneva: World Health Organisation, 2011.
3. World Economic Forum and the Harvard School of Public Health. The Global Economic Burden of Non-communicable Disease. 2011. http://www.weforum.org/EconomicsOfNCD. (accessed Jan 17, 2013).
4. WHO. Global tuberculosis report 2012. Geneva: World Health Organization. 2012.
5. Laxminarayan R, Klein E, Dye C, Floyd K, Darley S, Adeyi O. Economic Benefit of TB Control. 2007. http://www-wds.worldbank.org/external/default/WDSContentServer/IW3P/IB/2007/08/01/000158349_20070801103922/Rendered/PDF/wps4295.pdf (accessed Jan 17, 2013).
6. WHO. Multidrug and extensively drug-resistant TB (M/XDR-TB). 2010 global report on surveillance and response. Geneva: World Health Organization. 2010.
7. Schnippel K, Rosen S, Shearer K, et al. Costs of inpatient treatment for multi-drug-resistant tuberculosis in South Africa. Trop Med Int Health 2012; 18: 109-16.
8. Jeon CY, Murray MB. Diabetes mellitus increases the risk of active tuberculosis: a systematic review of 13 observational studies. PLoS Med 2008; 5: e152.
9. Stevenson CR, Forouhi NG, Roglic G, et al. Diabetes and tuberculosis: the impact of the diabetes epidemic on tuberculosis incidence. BMC Public Health 2007; 7: 234.
10. Baker MA, Harries AD, Jeon CY, et al. The impact of diabetes on tuberculosis treatment outcomes: a systematic review. BMC Medicine 2011; 9: 81.
11. Restrepo BI. Convergence of the tuberculosis and diabetes epidemics: renewal of old acquaintances. Clin Infect Dis 2007; 45: 436-38.
12. Oni T, Burke R, Tsekela R, et al. High prevalence of subclinical tuberculosis in HIV-1-infected persons without advanced immunodeficiency: implications for TB screening. Thorax 2011; 66: 669.
13. Dave JA, Lambert EV, Badri M, West S, Maartens G, Levitt NS. Effect of non-nucleoside reverse transcriptase inhibitor-based antiretroviral therapy on dysglycemia and insulin sensitivity in South African HIV-infected patients. J Acquir Immune Defic Syndr 2011; 57: 284-89.
14. Julius H, Basu D, Ricci E, et al. The burden of metabolic diseases amongst HIV positive patients on HAART attending the Johannesburg Hospital. Curr HIV Res 2011; 9: 247-52.
15. Thorogood M, Connor M, Tollman S, Lewando Hundt G, Fowkes G, Marsh J. A cross-sectional study of vascular risk factors in a rural South African population: data from the Southern African Stroke Prevention Initiative (SASPI). BMC Public Health 2007; 7: 326.
16. Peer N, Steyn K, Lombard C, Lambert EV, Vythilingum B, Levitt NS. Rising diabetes prevalence among urban-dwelling black South Africans. PLoS One 2012; 7: e43336.